3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine has been researched along with Hypertension, Renal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higaki, J; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Nishii, T; Ogihara, T; Tomita, N; Yo, Y | 1 |
1 other study(ies) available for 3-((2'-carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3h-imidazo(4,5-b)pyridine and Hypertension, Renal
Article | Year |
---|---|
Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Cilazapril; Data Interpretation, Statistical; Hepatocyte Growth Factor; Hydralazine; Hypertension, Renal; Imidazoles; Kidney; Kidney Tubules; Male; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Time Factors | 1999 |